Camarda Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,603
Closed -$389K 101
2020
Q4
$389K Hold
2,603
0.33% 61
2020
Q3
$344K Hold
2,603
0.42% 42
2020
Q2
$302K Buy
2,603
+379
+17% +$43.7K 0.42% 39
2020
Q1
$218K Hold
2,224
1.1% 28
2019
Q4
$323K Sell
2,224
-379
-15% -$52.3K 0.69% 43
2019
Q3
$347K Hold
2,603
0.81% 27
2019
Q2
$298K Hold
2,603
0.58% 31
2019
Q1
$323K Hold
2,603
0.62% 31
2018
Q4
$262K Hold
2,603
0.31% 37
2018
Q3
$332K Hold
2,603
0.38% 45
2018
Q2
$282K Hold
2,603
0.3% 60
2018
Q1
$276K Hold
2,603
0.29% 59
2017
Q4
$305K Hold
2,603
0.37% 56
2017
Q3
$296K Hold
2,603
0.32% 66
2017
Q2
$324K Hold
2,603
0.35% 63
2017
Q1
$309K Hold
2,603
0.3% 70
2016
Q4
$261K Hold
2,603
0.18% 91
2016
Q3
$329K Hold
2,603
0.2% 91
2016
Q2
$304K Hold
2,603
0.19% 87
2016
Q1
$269K Hold
2,603
0.17% 97
2015
Q4
$259K Hold
2,603
0.16% 85
2015
Q3
$237K Hold
2,603
0.15% 69
2015
Q2
$276K Hold
2,603
0.15% 65
2015
Q1
$297K Hold
2,603
0.17% 80
2014
Q4
$287K Hold
2,603
0.18% 84
2014
Q3
$254K Sell
2,603
-162
-6% -$15.9K 0.18% 73
2014
Q2
$279K Buy
2,765
+2,525
+1,052% +$246K 0.19% 85
2014
Q1
$22K Buy
+240
New +$22.1K 0.02% 132

Other funds holding ZBH

Camarda Financial Advisors's ZBH Position: Q1 2021 in Review

Camarda Financial Advisors sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 2,603 shares — an estimated $389K sold.

Camarda Financial Advisors first reported a position in ZBH in Q1 2014 and held it in 28 quarters. The position peaked at $389K in Q4 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Camarda Financial Advisors reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Camarda Financial Advisors sold 2,603 Zimmer Biomet shares in Q1 2021, an estimated $389K.
  • Camarda Financial Advisors first reported a position in Zimmer Biomet in Q1 2014 and held it in 28 quarters.
  • Camarda Financial Advisors's Zimmer Biomet position peaked at $389K in Q4 2020.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Camarda Financial Advisors's 13F filing for Q1 2021, filed 5 May 2021.